← Back to headlines
Avalo Therapeutics Reports GAAP EPS Beat at -$5.84, Revenue of $0.06M
Avalo Therapeutics announced its GAAP EPS of -$5.84, beating estimates by $0.47, with reported revenue reaching $0.06 million.
23 Mar, 11:07 — 23 Mar, 11:07
Sources
Showing 1 of 1 sources
Related Stories
Philippines Expects 1 Million Barrels of Diesel This Week to Cover Demand
just now
Philippines SSS Considers Relief Plans for Members and Employers
just now
Philippines Marks 32 Years of Internet Connectivity, DICT Pledges Wider Access
just now
Philippine Labor Department to Distribute P1.2 Billion in Aid After Holy Week
just now